Targeting MCPIP1 could provide a novel approach to modulate macrophage polarization, fibroblast activation, and splenic immune cell output, thereby enhancing the overall recovery and prognosis in patients with myocardial infarction. The gene discussed is ZC3H12A; the disease is myocardial infarction.